520
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Identifying and Treating Incarcerated Women Experiencing Substance Use Disorders: A Review

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon &
Pages 131-145 | Received 30 Aug 2023, Accepted 02 Nov 2023, Published online: 12 Nov 2023

References

  • Center for Behavioral Health Statistics and Quality (CBHSQ). Results from the 2020 National Survey on Drug Use and Health: detailed tables. U.S. Department of Health & Human Services, Substance Abuse and Mental Health Services Administration; 2021. Available from: https://www.samhsa.gov/data/report/2020-nsduh-detailed-tables. Accessed July 5, 2023.
  • Pitel L, Geckova AM, van Dijk JP, Reijneveld SA. Gender differences in adolescent health-related behaviour diminished between 1998 and 2006. Public Health. 2010;124(9):512–518. doi:10.1016/j.puhe.2010.05.005
  • Bronson J, Stroop J, Zimmer S, Berzofsky M. Drug use, dependence, and abuse among state prisoners and jail inmates, 2007–2009. U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2017. Available from: https://bjs.ojp.gov/content/pub/pdf/dudaspji0709.pdf. Accessed July 5, 2023.
  • Fazel S, Yoon IA, Hayes AJ. Substance use disorders in prisoners: an updated systematic review and meta-regression analysis in recently incarcerated men and women. Addict. 2017;112(10):1725–1739. doi:10.1111/add.13877
  • Monazzam N, Budd KM. Incarcerated women and girls. The Sentencing Project; April 3, 2023. Available from: https://www.sentencingproject.org/fact-sheet/incarcerated-women-and-girls/. Accessed July 19, 2023.
  • Herring T. Since you asked: what role does drug enforcement play in the rising incarceration of women; November 10, 2020. Available from: https://www.prisonpolicy.org/blog/2020/11/10/women-drug-enforcement/. Accessed July 19, 2023.
  • Maruschak LM, Bronson J, Alper M. Alcohol and drug use and treatment reported by prisoners. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2021. Available from: https://www.ojp.gov/library/publications/alcohol-and-drug-use-and-treatment-reported-prisoners-survey-prison-inmates. Accessed November 3, 2023.
  • Swavola E, Riley K, Subramanian R. Overlooked: women and jails in an era of reform. Vera Institute of Justice; August, 2016. Available from: https://www.vera.org/publications/overlooked-women-and-jails-report. Accessed July 5, 2023.
  • Volkow ND, Poznyak V, Saxena S, Gerra G. for UNODC-WHO Informal International Scientific Network. Drug use disorders: impact of a public health rather than a criminal justice approach. World Psychiatry. 2017;16(2):213–214. doi:10.1002/wps.20428
  • Volkow ND. Addiction should be treated, not penalized. Neuropsychopharmacology. 2021;46(12):2048–2050. doi:10.1038/s41386-021-01087-2
  • Johnson H. Drugs and crime: a study of incarcerated female offenders. Australian Research Institute, Research and Public Policy. Series No. 63; 2004. Available from: https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.498.8926&rep=rep1&type=pdf. Accessed November 3, 2023.
  • Chesney-Lind M, Pasko L, editors. The Female Offender: Girls, Women, and Crime. 3rd ed. Los Angeles: Sage; 2012.
  • Leverentz AM. The Ex-Prisoner’s Dilemma: How Women Negotiate Competing Narratives of Reentry and Desistance. New Brunswick, NJ: Rutgers University Press; 2014.
  • Visher CA, Travis J. Transitions from prison to community: understanding individual pathways. Annu Rev Sociol. 2003;29(1):89–113. doi:10.1146/annurev.soc.29.010202.095931
  • Wesely J, Dewey S. Confronting gendered pathways to incarceration: considerations for reentry programming. Soc Justice. 2018;45(1):57–82.
  • Salisbury EJ, Van Voorhis P. Gendered pathways: a quantitative investigation of women probationers’ paths to incarceration. Crim Justice Behav. 2009;36(6):541–566. doi:10.1177/0093854809334076
  • White W, Kurtz E. The varieties of recovery experience. Int J Self Help Self Care. 2006;3(1–2):21–61. doi:10.2190/911R-MTQ5-VJ1H-75CU
  • Lim S, Cherian T, Katyal M, et al. Association between jail‐based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011–17. Addict. 2023;118(3):459–467. doi:10.1111/add.16071
  • Amaro H, Black DS. Mindfulness-based intervention effects on substance use and relapse among women in residential treatment: a randomized controlled trial with 8.5-month follow-up period from the moment-by-moment in women’s recovery project. Psychosom Med. 2021;83(6):528. doi:10.1097/PSY.0000000000000907
  • Black DS, Amaro H. Moment-by-Moment in Women’s Recovery (MMWR): mindfulness-based intervention effects on residential substance use disorder treatment retention in a randomized controlled trial. Behav Res Ther. 2019;120:103437. doi:10.1016/j.brat.2019.103437
  • Moore KE, Roberts W, Reid HH, Smith KM, Oberleitner LM, McKee SA. Effectiveness of medication assisted treatment for opioid use in prison and jail settings: a meta-analysis and systematic review. J Subst Abuse Treat. 2019;99:32–43. doi:10.1016/j.jsat.2018.12.003
  • Sharma A, O’Grady KE, Kelly SM, et al. Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Subst Abuse Rehabil. 2016;7(1):27–40. doi:10.2147/SAR.S81602
  • Newbury-Birch D, Ferguson J, Landale S, et al. A systematic review of the efficacy of alcohol interventions for incarcerated people. Alcohol Alcohol. 2018;53(4):412–425. doi:10.1093/alcalc/agy032
  • Choi S, Rosenbloom D, Stein M, Raifman J, Clark J. Differential gateways, facilitators, and barriers to substance use disorder treatment for pregnant women and mothers: a scoping systematic review. J Addict Med. 2022;16(3):e185–e196. doi:10.1097/ADM.0000000000000909
  • Milavetz Z, Pritzl K, Muentner L, Poehlmann‐Tynan J. Unmet mental health needs of jailed parents with young children. Fam Relat. 2021;70(1):130–145. doi:10.1111/fare.12525
  • Stanton AE, Rose SJ. The mental health of mothers currently and formerly incarcerated in jails and prisons: an integrative review on mental health, mental health treatment, and traumatic experiences. J Forensic Nurs. 2020;16(4):224–231. doi:10.1097/JFN.0000000000000302
  • Murray J, Murray L. Parental incarceration, attachment and child psychopathology. Attach Hum Dev. 2010;12(4):289–309. doi:10.1080/14751790903416889
  • Fowler C, Rossiter C, Power T, Dawson A, Jackson D, Roche MA. Maternal incarceration: impact on parent–child relationships. J Child Health Care. 2022;26(1):82–95. doi:10.1177/13674935211000882
  • Sapkota D, Dennison S, Allen J, et al. Navigating pregnancy and early motherhood in prison: a thematic analysis of mothers’ experiences. Health Justice. 2022;10(1):32. doi:10.1186/s40352-022-00196-4
  • Tuerk EH, Loper AB. Contact between incarcerated mothers and their children: assessing parenting stress. J Offender Rehabil. 2006;43(1):23–43. doi:10.1300/J076v43n01_02
  • Nair S, McGreevy JE, Hutchinson-Colas J, Turock H, Chervenak F, Bachmann G. Pregnancy in incarcerated women: need for national legislation to standardize care. J Perinat Med. 2021;49(7):830–836. doi:10.1515/jpm-2021-0145
  • Sufrin C, Sutherland L, Beal L, Terplan M, Latkin C, Clarke JG. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study. Addict. 2020;115(11):2057–2065. doi:10.1111/add.15030
  • Kelsey CM, Medel N, Mullins C, Dallaire D, Forestell C. An examination of care practices of pregnant women incarcerated in jail facilities in the United States. Matern Child Health J. 2017;21:1260–1266. doi:10.1007/s10995-016-2224-5
  • Kramer C, Thomas K, Patil A, Hayes CM, Sufrin CB. Shackling and pregnancy care policies in US prisons and jails. Matern Child Health J. 2023;27(1):186–196. doi:10.1007/s10995-022-03526-y
  • Herreros-Fraile A, Carcedo RJ, Viedma A, et al. Parental incarceration, development, and well-being: a developmental systematic review. Int J Environ Res Public Health. 2023;20(4):3143. doi:10.3390/ijerph20043143
  • Green BL, Dass-Brailsford P, Hurtado de Mendoza A, et al. Trauma experiences and mental health among incarcerated women. Psychol Trauma. 2016;8(4):455–463. doi:10.1037/tra0000113
  • Karlsson ME, Zielinski MJ. Sexual victimization and mental illness prevalence rates among incarcerated women: a literature review. Trauma Violence Abuse. 2020;21(2):326–349. doi:10.1177/1524838018767933
  • Gil-Rivas V, Prause J, Grella CE. Substance use after residential treatment among individuals with co-occurring disorders: the role of anxiety/depressive symptoms and trauma exposure. Psychol Addict Behav. 2009;23(2):303–314. doi:10.1037/a0015355
  • Lynch SM, Fritch A, Heath NM. Looking beneath the surface: the nature of incarcerated women’s experiences of interpersonal violence, treatment needs, and mental health. Fem Criminol. 2012;7(4):381–400. doi:10.1177/1557085112439224
  • Scott CK, Dennis ML, Lurigio AJ. Comorbidity among female detainees in drug treatment: an exploration of internalizing and externalizing disorders. Psychiatr Rehabil J. 2015;38(1):35–44. doi:10.1037/prj0000134
  • Fuentes CM. Nobody’s child: the role of trauma and interpersonal violence in women’s pathways to incarceration and resultant service needs. Med Anthropol Q. 2014;28(1):85–104. doi:10.1111/maq.12058
  • Kubiak S, Covington S, Hillier C. Trauma-informed corrections. In: Springer D, Roberts A, editors. Social Work in Juvenile and Criminal Justice System. 4th ed. Springfield, IL: Charles C Thomas; 2017:92–104. Available from: https://www.stephaniecovington.com/site/assets/files/1518/soical_work_chapter_7_trauma-informed_corrections_final.pdf. Accessed July 2, 2023.
  • King EA. Outcomes of trauma-informed interventions for incarcerated women: a review. Int J Offender Ther Comp Criminol. 2017;61(6):667–688. doi:10.1177/0306624X15603082
  • Bronson J, Berzofsky M. Indicators of mental health problems reported by prisoners and jail inmates, 2011–2012. U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2017. Available from: https://www.bjs.gov/content/pub/pdf/imhprpji1112.pdf. Accessed July 5, 2023.
  • Baranyi G, Fazel S, Langerfeldt SD, Mundt AP. The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis. Lancet Public Health. 2022;7(6):e557–e568. doi:10.1016/S2468-2667(22)00093-7
  • Nowotny KM, Belknap J, Lynch S, DeHart D. Risk profile and treatment needs of women in jail with co-occurring serious mental illness and substance use disorders. Women Health. 2014;54(8):781–795. doi:10.1080/03630242.2014.932892
  • Lynch SM, Dehart DD, Belknap JE, et al. A multisite study of the prevalence of serious mental illness, PTSD, and substance use disorders of women in jail. Psychiatr Serv. 2014;65(5):670–674. doi:10.1176/appi.ps.201300172
  • Zlotnick C, Clarke JG, Friedmann PD, Roberts MB, Sacks S, Melnick G. Gender differences in comorbid disorders among offenders in prison substance abuse treatment programs. Behav Sci Law. 2008;26(4):403–412. doi:10.1002/bsl.831
  • Bose J, Hedden SL, Lipari RN, Park-Lee E, Porter JD, Pemberton MR. Key substance abuse indicators in the United States: results from the 2015 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration; 2016. Available from: https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2015/NSDUH-FFR1-2015/NSDUH-FFR1-2015.htm. Accessed July 2, 2023.
  • Hall EA, Prendergast ML, Wellisch J, Patten M, Cao Y. Treating drug-abusing women prisoners: an outcomes evaluation of the Forever Free program. Prison J. 2004;84(1):81–105. doi:10.1177/0032885503262456
  • Johnson JE, Schonbrun YC, Peabody ME, et al. Provider experiences with prison care and aftercare for women with co-occurring mental health and substance use disorders: treatment, resource, and systems integration challenges. J Behav Health Serv Res. 2015;42(4):417–436. doi:10.1007/s11414-014-9397-8
  • Centers for Disease Control and Prevention. Data and Statistics. Correctional Health; April 24, 2023. Available from: https://www.cdc.gov/correctionalhealth/health-data.html#:~:text=the%20general%20population.-,HIV,in%20the%20general%20U.S.%20population. Accessed July 27, 2023.
  • Loeliger KB, Biggs ML, Young R, et al. Gender differences in HIV risk behaviors among persons involved in the U.S. criminal justice system and living with HIV or at risk for HIV: a “seek, test, treat, and retain” harmonization consortium. AIDS Behav. 2017;21(10):2945–2957. doi:10.1007/s10461-017-1722-9
  • Tillson M, Strickland JC, Staton M. Age of first arrest, sex, and drug use as correlates of adult risk behaviors among rural women in jails. Women Crim Justice. 2017;27(5):287–301. doi:10.1080/08974454.2017.1291392
  • Dickson MF, Tillson M, Calvert JM, Staton M. Transactional sex among rural, justice-involved Appalachian women who use drugs. J Rural Health. 2023;39(4):789–794. doi:10.1111/jrh.12741
  • Knittel AK, Lambdin BH, Comfort ML, Kral AH, Lorvick J. Sexual risk and criminal justice involvement among women who use drugs. AIDS Behav. 2019;23(12):3366–3374. doi:10.1007/s10461-019-02447-2
  • Slavin MN, Hochstatter K, Kraus SW, Earleywine M, El-Bassel N. Associations between cannabis use and sexual risk behavior among women under community supervision: a brief report. Int J Sex Health. 2021;33(2):123–130. doi:10.1080/19317611.2020.1864558
  • Lorvick J, Comfort M, Kral AH, Lambdin BH. Exploring lifetime accumulation of criminal justice involvement and associated health and social outcomes in a community-based sample of women who use drugs. J Urban Health. 2018;95(4):584–593. doi:10.1007/s11524-017-0204-8
  • Staton M, Strickland JC, Webster JM, Leukefeld C, Oser C, Pike E. HIV prevention in rural Appalachian jails: implications for re-entry risk reduction among women who use drugs. AIDS Behav. 2018;22(12):4009–4018. doi:10.1007/s10461-018-2209-z
  • Young AM, Larian N, Havens JR. Gender differences in circumstances surrounding first injection experience of rural injection drug users in the United States. Drug Alcohol Depend. 2014;134:401–405. doi:10.1016/j.drugalcdep.2013.10.013
  • Sawyer W. The gender divide: tracking women’s state prison growth. Prison Policy Initiative; January 9, 2018. Available from: https://www.prisonpolicy.org/reports/women_overtime.html. Accessed July 2, 2023.
  • El-Bassel N, Marotta PL, Shaw SA, et al. Women in community corrections in New York City: HIV infection and risks. Int J STD AIDS. 2017;28(2):160–169. doi:10.1177/0956462416633624
  • Strickland JC, Staton M, Leukefeld CG, Oser CB, Webster JM. Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system. Int J Prison Health. 2018;14(2):89–100. doi:10.1108/IJPH-03-2017-0012
  • Fogel CI, Crandell JL, Neevel AM, et al. Efficacy of an adapted HIV and sexually transmitted infection prevention intervention for incarcerated women: a randomized controlled trial. Am J Public Health. 2015;105(4):802–809. doi:10.2105/AJPH.2014.302105
  • Gilbert L, Goddard-Eckrich D, Hunt T, et al. Efficacy of a computerized intervention on HIV and intimate partner violence among substance-using women in community corrections: a randomized controlled trial. Am J Public Health. 2016;106(7):1278–1286. doi:10.2105/AJPH.2016.303119
  • Knudsen HK, Staton-Tindall M, Oser CB, Havens JR, Leukefeld CG. Reducing risky relationships: a multisite randomized trial of a prison-based intervention for reducing HIV sexual risk behaviors among women with a history of drug use. AIDS Care. 2014;26(9):1071–1079. doi:10.1080/09540121.2013.878779
  • Bailey ZD, Feldman JM, Bassett MT. How structural racism works: racist policies as a root Cause of U.S. racial health inequities. N Engl J Med. 2021;384(8):768–773. doi:10.1056/NEJMms2025396
  • Powell AJ, Phelps MS. Gendered racial vulnerability: how women confront crime and criminalization. Law Soc Rev. 2021;55(3):429–451. doi:10.1111/lasr.12561
  • Proctor SL. Substance use disorder prevalence among female state prison inmates. Am J Drug Alcohol Abuse. 2012;38(4):278–285. doi:10.3109/00952990.2012.668596
  • Hedden BJ, Comartin E, Hambrick N, Kubiak S. Racial disparities in access to and utilization of jail- and community-based mental health treatment in 8 US midwestern jails in 2017. Am J Public Health. 2021;111(2):277–285. doi:10.2105/AJPH.2020.305992
  • Nowotny KM. Race/ethnic disparities in the utilization of treatment for drug dependent inmates in U.S. state correctional facilities. Addict Behav. 2015;40:148–153. doi:10.1016/j.addbeh.2014.09.005
  • Jordan BK, Federman EB, Burns BJ, Schlenger WE, Fairbank JA, Caddell JM. Lifetime use of mental health and substance abuse treatment services by incarcerated women felons. Psychiatr Serv. 2002;53(3):317–325. doi:10.1176/appi.ps.53.3.317
  • Timko C, Johnson JE, Kurth M, Schonbrun YC, Anderson BJ, Stein MD. Health services use among jailed women with alcohol use disorders. J Behav Health Serv Res. 2019;46(1):116–128. doi:10.1007/s11414-018-9634-7
  • Mahaffey C, Stevens-Watkins D, Knighton JS. Psychosocial determinants of health among incarcerated Black women: a systematic literature review. J Health Care Poor Underserved. 2016;27(2A):45–70. doi:10.1353/hpu.2016.0059
  • Gunn AJ, Sacks TK, Jemal A. ”That’s not me anymore”: resistance strategies for managing intersectional stigmas for women with substance use and incarceration histories. Qual Soc Work. 2018;17(4):490–508. doi:10.1177/1473325016680282
  • Staton M, Ciciurkaite G, Oser C, et al. Drug use and incarceration among rural Appalachian women: findings from a jail sample. Subst Use Misuse. 2018;53(6):931–941. doi:10.1080/10826084.2017.1385631
  • Willging CE, Nicdao EG, Trott EM, Kellett NC. Structural inequality and social support for women prisoners released to rural communities. Women Crim Justice. 2016;26(2):145–164. doi:10.1080/08974454.2015.1067174
  • Staton-Tindall M, McNees E, Leukefeld C, et al. Treatment utilization among metropolitan and nonmetropolitan participants of corrections-based substance abuse programs reentering the community. J Soc Serv Res. 2011;37(4):379–389. doi:10.1080/01488376.2011.582019
  • Browne T, Priester MA, Clone S, Iachini A, DeHart D, Hock R. Barriers and facilitators to substance use treatment in the rural south: a qualitative study. J Rural Health. 2016;32(1):92–101. doi:10.1111/jrh.12129
  • Zajac G, Hutchison R, Meyer CA. An examination of rural prisoner reentry challenges. Harrisburg, PA: Center for Rural Pennsylvania; 2014. Available from: https://cjrc.la.psu.edu/wp-content/uploads/sites/21/2020/10/CRPA-Rural-Reentry-Report-Final-Justice-Center-version.pdf. Accessed July 5, 2023.
  • Lister JJ, Weaver A, Ellis JD, Himle JA, Ledgerwood DM. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. Am J Drug Alcohol Abuse. 2020;46(3):273–288. doi:10.1080/00952990.2019.1694536
  • Edmond MB, Aletraris L, Roman PM. Rural substance use treatment centers in the United States: an assessment of treatment quality by location. Am J Drug Alcohol Abuse. 2015;41(5):449–457. doi:10.3109/00952990.2015.1059842
  • Scroggins JR, Malley S. Reentry and the (unmet) needs of women. J Offender Rehabil. 2010;49(2):146–163. doi:10.1080/10509670903546864
  • Staton M, Pike E, Tillson M, Lofwall MR. Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice‐involved individuals in rural Appalachia. J Community Psychol. 2023. doi:10.1002/jcop.23029
  • Beichner D, Rabe-Hemp C. “I don’t want to go back to that town:” Incarcerated mothers and their return home to rural communities. Crit Criminol. 2014;22:527–543. doi:10.1007/s10612-014-9253-4
  • Lichter DT, Ziliak JP. The rural-urban interface: new patterns of spatial interdependence and inequality in America. Ann Am Acad Political Soc Sci. 2017;672(1):6–25. doi:10.1177/0002716217714180
  • Moody LN, Satterwhite E, Bickel WK. Substance use in rural Central Appalachia: current status and treatment considerations. J Rural Ment Health. 2017;41(2):123–135. doi:10.1037/rmh0000064
  • Keyes KM, Cerda M, Brady JE, Havens JR, Galea S. Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health. 2014;104(2):e52–9. doi:10.2105/AJPH.2013.301709
  • Tillson M, Dickson MF, Webster JM, Staton M. Community relationship quality and reincarceration following rural drug-using women’s reentry from jail. Crim Just Behav. 2022;49(6):853–871. doi:10.1177/00938548211073603
  • Ledesma E, Ford CL. Health Implications of housing assignments for incarcerated transgender women. Am J Public Health. 2020;110(5):650–654. doi:10.2105/AJPH.2020.305565
  • Meyer IH. Prejudice and discrimination as social stressors. In: Meyer IH, Northridge ME, editors. The Health of Sexual Minorities. Boston, MA: Springer; 2007:242–267. doi:10.1007/978-0-387-31334-4_10
  • Hatzenbuehler ML, Pachankis JE. Stigma and minority stress as social determinants of health among lesbian, gay, bisexual, and transgender youth: research evidence and clinical implications. Pediatr Clin North Am. 2016;63(6):985–997. doi:10.1016/j.pcl.2016.07.003
  • Hughto JMW, Quinn EK, Dunbar MS, Rose AJ, Shireman TI, Jasuja GK. Prevalence and co-occurrence of alcohol, nicotine, and other substance use disorder diagnoses among US transgender and cisgender adults. JAMA Netw Open. 2021;4(2):e2036512. doi:10.1001/jamanetworkopen.2020.36512
  • Peralta RL, Victory E, Thompson CL. Alcohol use disorder in sexual minority adults: age- and sex- specific prevalence estimates from a national survey, 2015–2017. Drug Alcohol Depend. 2019;205:107673. doi:10.1016/j.drugalcdep.2019.107673
  • Schuler MS, Collins RL. Sexual minority substance use disparities: bisexual women at elevated risk relative to other sexual minority groups. Drug Alcohol Depend. 2020;206:107755. doi:10.1016/j.drugalcdep.2019.107755
  • Paschen-Wolff MM, Velasquez R, Aydinoglo N, Campbell ANC. Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States. J Subst Abuse Treat. 2022;140:108828. doi:10.1016/j.jsat.2022.108828
  • Braunstein MD. The five stages of LGBTQ discrimination and its effects on mass incarceration. U Miami Race Soc Just L Rev. 2017;7:217–246.
  • Girouard MP, Goldhammer H, Keuroghlian AS. Understanding and treating opioid use disorders in lesbian, gay, bisexual, transgender, and queer populations. Subst Abus. 2019;40(3):335–339. doi:10.1080/08897077.2018.1544963
  • Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800. doi:10.1093/cid/ciq243
  • Belenko S, Knight D, Wasserman GA, et al. The Juvenile Justice Behavioral Health Services Cascade: a new framework for measuring unmet substance use treatment services needs among adolescent offenders. J Subst Abuse Treat. 2017;74:80–91. doi:10.1016/j.jsat.2016.12.012
  • Knight DK, Belenko S, Dennis ML, et al. The comparative effectiveness of Core versus Core+Enhanced implementation strategies in a randomized controlled trial to improve substance use treatment receipt among justice-involved youth. BMC Health Serv Res. 2022;22(1):1535. doi:10.1186/s12913-022-08902-6
  • Williams A, Nunes E, Olfson M. To battle the opioid overdose epidemic, deploy the ‘cascade of care’ model. Health Affairs; March 13, 2017. Available from: https://www.healthaffairs.org/content/forefront/battle-opioid-overdose-epidemic-deploy-cascade-care-model. Accessed July 23, 2023.
  • Scott CK, Dennis ML, Grella CE, Mischel AF, Carnevale J. The impact of the opioid crisis on US state prison systems. Health Justice. 2021;9(17):1–16.
  • Zaller N, Donadeo K, Coffey J, Zielinski M, Brinkley-Rubinstein L. Screening for opioid use disorder in the largest jail in Arkansas: a brief report. J Correct Health Care. 2019;25(3):214–218. doi:10.1177/1078345819852133
  • Humeniuk R, Ali R. Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and pilot brief intervention: a technical report of Phase II findings of the WHO ASSIST Project. World Health Organization; 2006. Available from: https://apps.who.int/iris/handle/10665/43504. Accessed July 23, 2023.
  • [NIDA] National Institute on Drug Abuse (2009). NIDA modified-ASSIST; July 20, 2023. Available from: https://nida.nih.gov/sites/default/files/pdf/nmassist.pdf. Accessed November 3, 2023.
  • Staton M, Tillson M, Levi MM, Webster JM, Oser CB, Leukefeld C. Screening incarcerated women for opioid use disorder (OUD). J Drug Issues. 2023. doi:10.1177/00220426231151595
  • Wolff N, Shi J. Screening for substance use disorder among incarcerated men with the Alcohol, Smoking, Substance Involvement Screening Test (ASSIST): a comparative analysis of computer-administered and interviewer-administered modalities. J Subst Abuse Treat. 2015;53:22–32. doi:10.1016/j.jsat.2015.01.006
  • Dawson‐Rose C, Shehadeh D, Hao J, et al. Trauma, substance use, and mental health symptoms in transitional age youth experiencing homelessness. Public Health Nurs. 2020;37(3):363–370. doi:10.1111/phn.12727
  • Shuper PA, Joharchi N, Bogoch II, et al. Alcohol consumption, substance use, and depression in relation to HIV Pre-Exposure Prophylaxis (PrEP) nonadherence among gay, bisexual, and other men-who-have-sex-with-men. BMC Public Health. 2020;20(1):1782–1782. doi:10.1186/s12889-020-09883-z
  • Lee CT, Lin CY, Koós M, et al. The eleven-item Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-11): cross- cultural psychometric evaluation across 42 countries. J Psychiatr Res. 2023;165:16–27. doi:10.1016/j.jpsychires.2023.06.033
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, D.C; 2013. doi:10.1176/appi.books.9780890425596
  • Centers for Disease Control and Prevention. Module 5: assessing and addressing opioid use disorder (OUD); 2021. Available from: https://www.cdc.gov/drugoverdose/training/oud/accessible/index.html. Accessed November 3, 2023.
  • Substance Abuse and Mental Health Services Administration. Medicaid coverage of medication-assisted treatment for alcohol and opioid use disorders and of medication for the reversal of opioid overdose; November, 2018. Available from: https://store.samhsa.gov/product/Medicaid-Coverage-of-Medication-Assisted-Treatment-for-Alcohol-and-Opioid-Use-Disorders-and-of-Medication-for-the-Reversal-of-Opioid-Overdose/SMA18-5093. Accessed July 23, 2023.
  • Dela Cruz AM, Walker R, Pipes R, et al. Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care. Addict Sci Clin Pract. 2021;16(1):12. doi:10.1186/s13722-021-00222-0
  • You DS, Mardian AS, Darnall BD, et al. A brief screening tool for opioid use disorder: EMPOWER study expert consensus protocol. Front Med. 2021;8:591201. doi:10.3389/fmed.2021.591201
  • Dunn KE, Barrett FS, Fingerhood M, Bigelow GE. Opioid overdose history, risk behaviors, and knowledge in patients taking prescribed opioids for chronic pain. Pain Med. 2017;18(8):1505–1515. doi:10.1093/pm/pnw228
  • Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301(2):183–190. doi:10.1001/jama.2008.976
  • Inciardi JA, Martin SS, Butzin CA. Five-year outcomes of therapeutic community treatment of drug-involved offenders after release from prison. Crime Delinq. 2004;50(1):88–107. doi:10.1177/0011128703258874
  • Harrison LD, Butzin CA, Inciardi JA, Martin SS. Integrating HIV-prevention strategies in a therapeutic community work-release program for criminal offenders. Prison J. 1998;78(3):232–243. doi:10.1177/0032885598078003003
  • Lockwood D, McCorkel J, Inciardi JA. Developing comprehensive prison-based therapeutic community treatment for women. Drugs Soc. 1998;13(1–2):193–212. doi:10.1300/J023v13n01_12
  • Sacks JY, McKendrick K, Hamilton Z. A randomized clinical trial of a therapeutic community treatment for female inmates: outcomes at 6 and 12 months after prison release. J Addict Dis. 2012;31(3):258–269. doi:10.1080/10550887.2012.694601
  • Hedrich D, Alves P, Farrell M, et al. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addict. 2011;107(3):501–517. doi:10.1111/j.1360-0443.2011.03676.x
  • Lee JD, Friedmann PD, Boney TY, et al. Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial. Contemp Clin Trials. 2015;41:110–117. doi:10.1016/j.cct.2015.01.005
  • Lee JD, Nunes EV, Bailey GL, et al. NIDA Clinical Trials Network CTN-0051, extended-release naltrexone vs. buprenorphine for opioid treatment (X: BOT): study design and rationale. Contemp Clin Trials. 2016;50:253–264. doi:10.1016/j.cct.2016.08.004
  • Staton M, Webster JM, Leukefeld C, et al. Kentucky Women’s Justice Community Opioid Innovation Network (JCOIN): a type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-involved women. J Subst Abuse Treat. 2021;128:108284. doi:10.1016/j.jsat.2021.108284
  • Taylor E, Timko C, Harris AHS, Yu M, Finlay AK. Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration. Addict Sci Clin Pract. 2019;14(1):1. doi:10.1186/s13722-018-0129-x
  • Najavits L. Seeking Safety: A Treatment Manual for PTSD and Substance Abuse. New York, NY: Guilford Press; 2001.
  • Najavits LM, Hien D. Helping vulnerable populations: a comprehensive review of the treatment outcome literature on substance use disorder and PTSD. J Clin Psychol. 2013;69(5):433–479. doi:10.1002/jclp.21980
  • Lynch SM, Heath NM, Mathews KC, Cepeda GJ. Seeking safety: an intervention for trauma-exposed incarcerated women? J Trauma Dissociation. 2012;13(1):88–101. doi:10.1080/15299732.2011.608780
  • Zlotnick C, Johnson J, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009;40(4):325–336. doi:10.1016/j.beth.2008.09.004
  • Henderson A, Kroese BS. Group interventions for trauma and substance misuse available for women in criminal justice services: a systematic review of the literature. J Forensic Pract. 2020;22(4):235–249. doi:10.1108/JFP-05-2020-0024
  • Johnstone S, Dela Cruz GA, Kalb N, et al. A systematic review of gender-responsive and integrated substance use disorder treatment programs for women with co-occurring disorders. Am J Drug Alcohol Abuse. 2023;49(1):21–42. doi:10.1080/00952990.2022.2130348
  • Sherman ADF, Balthazar M, Zhang W, et al. Seeking safety intervention for comorbid post-traumatic stress and substance use disorder: a meta-analysis. Brain Behav. 2023;13(5):e2999. doi:10.1002/brb3.2999
  • Covington SS, Burke C, Keaton S, Norcott C. Evaluation of a trauma-informed and gender-responsive intervention for women in drug treatment. J Psychoactive Drugs. 2008;Suppl 5:387–398. doi:10.1080/02791072.2008.10400666
  • Messina N, Calhoun S, Braithwaite J. Trauma-informed treatment decreases posttraumatic stress disorder among women offenders. J Trauma Dissociation. 2014;15(1):6–23. doi:10.1080/15299732.2013.818609
  • Riley BJ, Smith D, Baigent MF. Mindfulness and acceptance-based group therapy: an uncontrolled pragmatic pre-post pilot study in a heterogeneous population of female prisoners. Int J Offender Ther Comp Criminol. 2019;63(15–16):2572–2585. doi:10.1177/0306624X19858487
  • McKim A. Addicted to Rehab: Race, Gender, and Drugs in the Era of Mass Incarceration. New Brunswick, NJ: Rutgers University Press; 2017.
  • Morash M. Women on Probation and Parole: A Feminist Critique of Community Programs and Services. Boston: Northeastern University Press; 2010.
  • Grella CE, Ostlie E, Watson DP, Scott CK, Carnevale J, Dennis ML. Scoping review of interventions to link individuals to substance use services at discharge from jail. J Subst Abuse Treat. 2022;138:108718. doi:10.1016/j.jsat.2021.108718
  • Zweben JE. Women’s treatment in criminal justice settings. In: Leukefeld C, Gulotta TP, Gregrich J, editors. Handbook of Evidence-Based Substance Abuse Treatment in Criminal Justice Settings. New York: Springer; 2011:229–244.
  • Bunting AM, Oser C, Staton M, Knudsen H. Polysubstance use patterns among justice-involved individuals who use opioids. Subst Use Misuse. 2020;55(13):2165–2174. doi:10.1080/10826084.2020.1795683
  • Zgoba KM, Reeves R, Tamburello A, Debilio L. Criminal recidivism in inmates with mental illness and substance use disorders. J Am Acad Psychiatry Law. 2020;48(2):209–215. doi:10.29158/JAAPL.003913-20
  • Pizzicato LN, Drake R, Domer-Shank R, Johnson CC, Viner KM. Beyond the walls: risk factors for overdose mortality following release from the Philadelphia Department of Prisons. Drug Alcohol Depend. 2018;189:108–115. doi:10.1016/j.drugalcdep.2018.04.034
  • Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159(9):592–600. doi:10.7326/0003-4819-159-9-201311050-00005
  • Ataiants J, Mazzella S, Roth AM, Robinson LF, Sell RL, Lankenau SE. Multiple victimizations and overdose among women with a history of illicit drug use. J Interpers Violence. 2022;37(3–4):NP1588–NP1613. doi:10.1177/0886260520927501
  • Scheidell JD, Hoff L, Khan MR, Bennett AS, Elliott L. Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City. Drug Alcohol Depend Rep. 2022;3. doi:10.1016/j.dadr.2022.100054
  • Jason LA, Salomon-Amend M, Guerrero M, Bobak T, O’Brien J, Soto-Nevarez A. The emergence, role, and impact of recovery support services. Alcohol Res. 2021;41(1):04. doi:10.35946/arcr.v41.1.04
  • Reingle Gonzalez JM, Rana RE, Jetelina KK, Roberts MH. The value of lived experience with the criminal justice system: a qualitative study of peer re-entry specialists. Int J Offender Ther Comp Criminol. 2019;63(10):1861–1875. doi:10.1177/0306624X19830596
  • Stack E, Hildebran C, Leichtling G, et al. Peer recovery support services across the continuum: in community, hospital, corrections, and treatment and recovery agency settings - a narrative review. J Addict Med. 2022;16(1):93–100. doi:10.1097/ADM.0000000000000810
  • Substance Abuse and Mental Health Services Administration. Guidelines for successful transition of people with mental or substance use disorders from jail and prison: implementation guide. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2017. Available from: https://store.samhsa.gov/product/Guidelines-for-Successful-Transition-of-People-with-Mental-or-Substance-Use-Disorders-from-Jail-and-Prison-Implementation-Guide/SMA16-4998. Accessed July 5, 2023.
  • Heidemann G, Cederbaum JA, Martinez S. “We walk through it together”: the importance of peer support for formerly incarcerated women’s success. J Offender Rehabil. 2014;53(7):522–542. doi:10.1080/10509674.2014.944741
  • Tillson M, Fallin-Bennett A, Staton M. Providing peer navigation services to women with a history of opioid misuse pre- and post-release from jail: a program description. J Clin Transl Sci. 2022;6(1):e106. doi:10.1017/cts.2022.441
  • Cobbina JE, Huebner BM, Berg MT. Men, women, and postrelease offending: an examination of the nature of the link between relational ties and recidivism. Crime Delinq. 2012;58(3):331–361. doi:10.1177/0011128710382348
  • Snell-Rood C, Staton-Tindall M, Victor G. Incarcerated women’s relationship-based strategies to avoid drug use after community re-entry. Women Health. 2016;56(7):843–858. doi:10.1080/03630242.2015.1118732
  • Johnson IM. Women parolees’ perceptions of parole experiences and parole officers. Am J Crim Justice. 2015;40(4):785–810. doi:10.1007/s12103-014-9284-0
  • Morash M, Kashy DA, Smith SW, Cobbina JE. The effects of probation or parole agent relationship style and women offenders’ criminogenic needs on offenders’ responses to supervision interactions. Crim Justice Behav. 2015;42(4):412–434. doi:10.1177/0093854814551602
  • Miller HV. Female re-entry and gender-responsive programming. U.S. Department of Justice, Office of Justice Programs, National Institute of Justice; 2021. Available from: https://nij.ojp.gov/topics/articles/female-reentry-and-gender-responsive-programming. Accessed July 5, 2023.
  • Marsden J, Stillwell G, Jones H, et al. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addict. 2017;112(8):1408–1418. doi:10.1111/add.13779
  • Evans EA, Wilson D, Friedmann PD. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug Alcohol Depend. 2022;231:109254. doi:10.1016/j.drugalcdep.2021.109254
  • Gan WQ, Kinner SA, Nicholls TL, et al. Risk of overdose-related death for people with a history of incarceration. Addict. 2021;116(6):1460–1471. doi:10.1111/add.15293
  • Park TW, Larochelle MR, Saitz R, Wang N, Bernson D, Walley AY. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine. Addict. 2020;115(5):924–932. doi:10.1111/add.14886
  • Ranapurwala SI, Shanahan ME, Alexandridis AA, et al. Opioid overdose mortality among former North Carolina inmates: 2000–2015. Am J Public Health. 2018;108(9):1207–1213. doi:10.2105/AJPH.2018.304514
  • El-Bassel N, Marotta PL, Goddard-Eckrich D, et al. Drug overdose among women in intimate relationships: the role of partner violence, adversity and relationship dependencies. PLoS One. 2019;14(12):e0225854. doi:10.1371/journal.pone.0225854
  • Thumath M, Humphreys D, Barlow J, et al. Overdose among mothers: the association between child removal and unintentional drug overdose in a longitudinal cohort of marginalised women in Canada. Int J Drug Policy. 2021;91:102977. doi:10.1016/j.drugpo.2020.102977